lung SBRT, ESAS, anxiety
Showing 26 - 50 of >10,000
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
-
Duarte, California
- +1 more
Aug 24, 2023
SBRT in Reirradiation for Ultra-central Thoracic Malignant
Recruiting
- Stereotactic Body Radiation Therapy
- +3 more
- stereotacitic body radiation therapy
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Dual Energy Computed Tomography in Thoracic Radiotherapy
Completed
- Lung Cancer
- +2 more
- Thoracic radiotherapy
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Nov 11, 2022
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Stage IV NSCLC Trial in Wuhan (SBRT+Osimertinib, Osimertinib 80 MG)
Not yet recruiting
- Stage IV Non-small Cell Lung Cancer
- SBRT+Osimertinib
- Osimertinib 80 MG
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated to Tongji Medical College of Huazhong
Oct 13, 2022
Non Small Cell Lung Cancer Trial in Buffalo (SBRT)
Recruiting
- Non Small Cell Lung Cancer
- SBRT
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 27, 2022
Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),
Recruiting
- Metastatic Neoplasm to the Spine
- Metastatic Neoplasm
- Conventional external beam radiation therapy dose (EBRT)
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 24, 2023
Stereotactic Body Radiation Therapy Trial in Beijing (drug adjuvant therapy)
Not yet recruiting
- Stereotactic Body Radiation Therapy
- drug adjuvant therapy
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology Cancer Center, Peking Universit
Jun 6, 2022
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
The Efficacy and Safety of SBRT in MPLC Trial in Changsha (NO Intervention)
Recruiting
- The Efficacy and Safety of SBRT in MPLC
- NO Intervention
-
Changsha, Hunan, ChinaOncology Department,Second Xiangya Hospital of Central South Uni
Aug 22, 2022
Early Stage NSCLC Trial in Philadelphia (Vancomycin, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Early Stage Non-Small Cell Lung Cancer
- Vancomycin
- Stereotactic Body Radiation Therapy (SBRT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 1, 2022
Lung Non-Small Cell Carcinoma Trial in Columbus (procedure, drug, radiation)
Recruiting
- Lung Non-Small Cell Carcinoma
- Blood Oxygen Level Dependent Imaging
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 9, 2022
Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)
Recruiting
- Unresectable Hepatocellular Carcinoma
- Oligometastatic Disease
- SBRT plus tislelizumab and regorafenib
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jun 15, 2023
Lung Cancer Trial in Heidelberg (Stereotactic body radiotherapy (SBRT))
Recruiting
- Lung Cancer
- Stereotactic body radiotherapy (SBRT)
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022
Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)
Recruiting
- Pancreatic Cancer
- Stereotactic body radiation therapy plus vNKT cell adoptive therapy
-
Shanghai, ChinaChanghai Hospital affiliated to Naval Medical University
Mar 13, 2023
Stereotactic Body Radiotherapy for Medically Inoperable
Recruiting
- Kidney Neoplasm
- +2 more
- SBRT
-
Terrassa, Barcelona, SpainConsorci Sanitari de Terrassa
Apr 5, 2023
Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)
Not yet recruiting
- Ovarian Cancer Recurrent
- Niraparib oral capsule
- SBRT
-
Sutton, Surrey, United Kingdom
- +1 more
Aug 10, 2023
NSCLC Trial in New Haven (45 Gray (Gy) regimen)
Recruiting
- Non-small Cell Lung Cancer
- 45 Gray (Gy) regimen
-
New Haven, ConnecticutSmilow Cancer Hospital
Jul 20, 2022
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
Spine Metastases, Radiation Therapy, Pain Trial in Montréal (Vertebroplasty, Stereotactic Body Radiation Therapy only)
Not yet recruiting
- Spine Metastases
- +2 more
- Vertebroplasty
- Stereotactic Body Radiation Therapy only
-
Montréal, Quebec, CanadaVéronique Freire
Jan 25, 2023
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Soft Tissue Sarcoma Trial in France (SBRT + MEDI5752)
Not yet recruiting
- Soft Tissue Sarcoma
- SBRT + MEDI5752
-
Bordeaux, France
- +4 more
Apr 7, 2023
NSCLC Trial in Wuhan (Camrelizumab, Apatinib, Docetaxel injection)
Recruiting
- Non-Small Cell Lung Cancer
- Camrelizumab
- +4 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Apr 29, 2022
SBRT in Treatment of Thoracic Malignant Tumors at Different
Recruiting
- Radiotherapy
- +2 more
- stereotactic body radiation therapy
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Guangzhou (PD-1 combined with SBRT)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Oligometastatic Disease
- PD-1 combined with SBRT
-
Guangzhou, Guangdong, ChinaMian Xi
Dec 18, 2022